ArticleActa Cardiologica Sinica2019

Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation.

Shih-Wei Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.